Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research

@article{Breems2005AutologousBM,
  title={Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research },
  author={Dimitri A Breems and Marc A. Boogaerts and Adriaan W Dekker and Wim L J van Putten and P. Sonneveld and Peter C. Huijgens and Johannes van der Lelie and Edo Vellenga and Alois A Gratwohl and Gregor E. G. Verhoef and Leo F. Verdonck and Bob L{\"o}wenberg},
  journal={British journal of haematology},
  year={2005},
  volume={128 1},
  pages={59-65}
}
The question as to whether autologous stem cell transplantation (SCT) after consolidation chemotherapy improves the probability of survival of patients with acute myeloid leukaemia (AML) in first remission has not been settled. Here, we present the results of a phase III study conducted in newly diagnosed adult AML patients aged <60 years. Patients who had reached a complete remission (CR) after two courses of induction chemotherapy and who were not eligible for a human leucocyte antigen… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 29 extracted citations

Similar Papers

Loading similar papers…